BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7352279)

  • 1. Buprenorphine suppresses heroin use by heroin addicts.
    Mello NK; Mendelson JH
    Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine responders: a diagnostic subgroup of heroin addicts?
    Resnick RB; Resnick E; Galanter M
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(4):531-8. PubMed ID: 1749829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine: a new maintenance opiate?
    Seow SS; Quigley AJ; Ilett KF; Dusci LJ; Swensen G; Harrison-Stewart A; Rappeport L
    Med J Aust; 1986 Apr; 144(8):407-11. PubMed ID: 3959968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of buprenorphine for the treatment of opioid dependence.
    Johnson RE; Fudala PJ
    NIDA Res Monogr; 1992; 121():120-41. PubMed ID: 1383825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral pharmacology of buprenorphine.
    Mello NK; Mendelson JH
    Drug Alcohol Depend; 1985 Feb; 14(3-4):283-303. PubMed ID: 3888577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
    Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
    J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
    Schottenfeld RS; Chawarski MC; Mazlan M
    Lancet; 2008 Jun; 371(9631):2192-200. PubMed ID: 18586174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence].
    Wang Y; Tang C; Cheng S; Cui G; Zhang R; Zhang Z; Xie L; Lin Y; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):117-22. PubMed ID: 25769319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
    Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L
    Addiction; 2002 Nov; 97(11):1395-404. PubMed ID: 12410780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine as new treatment for heroin dependence.
    Reisinger M
    Drug Alcohol Depend; 1985 Dec; 16(3):257-62. PubMed ID: 4092611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
    Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1988 Jan; 43(1):72-8. PubMed ID: 3275523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine: an alternative to methadone for heroin dependence treatment.
    Resnick RB; Galanter M; Pycha C; Cohen A; Grandison P; Flood N
    Psychopharmacol Bull; 1992; 28(1):109-13. PubMed ID: 1609035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
    Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
    Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.